NCT07211919

Brief Summary

This study looks at the effects of accelerated intermittent theta burst stimulation (aiTBS) on patients with chronic and acute post-concussion syndrome. Each participant was treated in an outpatient setting for about 3 hours per day, over 3 days. The participants' symptom survey scores and brain scan data were then compared before and after treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 1, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 8, 2025

Completed
Last Updated

October 10, 2025

Status Verified

October 1, 2025

Enrollment Period

2 months

First QC Date

October 1, 2025

Last Update Submit

October 8, 2025

Conditions

Keywords

Post Concussion SyndromefMRI Transcranial Magnetic StimulationAccelerated Intermittent Theta BurstFunctional Neuroimaging

Outcome Measures

Primary Outcomes (4)

  • Post-Concussion Symptom Scale (PCSS) Score

    PCSS (post-concussion symptom scale) is a 21-question Likert scale questionnaire regarding physical, cognitive, sleep, and emotional symptoms of post-concussion syndrome. Minimum score on the scale is zero, maximum score is 126. Higher score indicates more severe symptoms.

    Scores taken prior to intervention, immediately post-intervention, and 1-4 weeks post-intervention

  • Beck Anxiety Inventory (BAI) Score

    Beck Anxiety Inventory is a 21-question Likert scale questionnaire used for measuring severity of anxiety symptoms. Minimum score is zero, maximum score is 63. Higher score indicates more severe symptoms.

    Immediately prior to treatment, after treatment, and 1-4 weeks post-treatment

  • Beck Depression Inventory (BDI) Score

    Beck Depression Inventory is a 21-question multiple choice self-report inventory used for measuring severity of depression. Minimum score is zero, maximum score is 63. Higher scores indicate more severe symptoms.

    Pre-treatment, immediately post-treatment, and 1-4 weeks post-treatment.

  • Functional Neurocognitive Imaging (fNCI) Score

    The fNCI assessment protocol combines the validity of conventional neuropsychological testing standards with the reliability and objectivity of informational data output provided by fMRI. It is a scan comparing BOLD signal and blood flow from participant's brain scan against a normative database of healthy, non-injured brains. Higher scores represent further deviation from healthy baseline, with a minimum score of zero and no theoretical maximum score. Scores below 1 are within healthy range.

    1-4 weeks pre-treatment, 1-4 weeks post-treatment

Study Arms (1)

Post-Concussion Symptom Participants

Participants experiencing chronic or acute symptoms resulting from a mild traumatic brain injury

Eligibility Criteria

Age16 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants were primarily recruited from referrals to Neural Effects (an insurance-based acute concussion care center tied to Cognitive FX). Additional patients were recruited from word-of-mouth referrals to our clinic for concussion care.

You may qualify if:

  • Chronic or acute concussion symptoms

You may not qualify if:

  • MDD, GAD, bipolar depression, PTSD, schizophrenia, metal implants in skull, pacemaker, history of seizures, epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cognitive FX TMS Clinic

Provo, Utah, 84604, United States

Location

MeSH Terms

Conditions

Post-Concussion Syndrome

Condition Hierarchy (Ancestors)

Brain ConcussionHead Injuries, ClosedCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesWounds and InjuriesWounds, Nonpenetrating

Study Officials

  • Mark Allen, PhD

    Cognitive FX

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2025

First Posted

October 8, 2025

Study Start

May 1, 2025

Primary Completion

June 30, 2025

Study Completion

July 31, 2025

Last Updated

October 10, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

IPD will not be shared unless other researchers sign a data use agreement outlining a plan to use IPD that does not include any form of identifiable PHI.

Locations